Skip to main navigation

About
- Company
- Leadership
- Laboratory
- Careers
Products
Applications
Technology
Resources
- What’s New
- Conferences
- Library
- Blog
- Contact
Investors

Press Releases

Press Releases

Year

Aug 16, 2022

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 15, 2022

Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers

Aug 04, 2022

Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Aug 03, 2022

Personalis Reports Second Quarter 2022 Financial Results

Aug 02, 2022

Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics

Jul 20, 2022

Personalis to Announce Second Quarter 2022 Financial Results

Jul 12, 2022

Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease

May 04, 2022

Personalis Reports First Quarter 2022 Financial Results

Apr 28, 2022

Personalis to Present at Upcoming Investor Conferences

Apr 26, 2022

Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 24

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website

© 2022 Personalis Inc. All rights reserved.